Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Nutrition ; 30(3): 319-25, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24296036

ABSTRACT

OBJECTIVES: To evaluate the effect of effect of Yellow Capsicum extract (YCE) that is rich in capsaicin on the proliferation and differentiation of 3T3-L1 preadipocytes in vitro. METHODS: 3T3 L1 cells that were exposed to differentiation-inducing medium containing high glucose DMEM (Dulbecco's Modified Eagle's Medium) and subsequently were treated with capsaicin and YCE for their effect on adipocyte differentiation, changes in their triglyceride content, leptin secretion, expression of lipoprotein lipase, PPARγ, and CCAAT/enhancer-binding protein alpha (C/EBPα). RESULTS: Both YCE and capsaicin inhibited proliferation and differentiation 3T3-L1 preadipocytes and suppressed accumulation of intracellular triglyceride in a dose-dependent manner. In addition, a significant decrease in the expression of lipoprotein lipase (LPL), leptin, PPARγ, and C/EBPα was noted in 3T3-L1 preadipocytes when induced to differentiate by YCE and Capsaicin. CONCLUSIONS: The potent inhibitory action of YCE and Capsaicin on the differentiation of 3T3-L1 preadipocyte observed suggests that they (YCE and Capsaicin) have the potential to inhibit obesity that needs to be explored in future studies.


Subject(s)
Capsicum/chemistry , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Plant Extracts/pharmacology , 3T3-L1 Cells , Animals , CCAAT-Enhancer-Binding Protein-alpha/genetics , CCAAT-Enhancer-Binding Protein-alpha/metabolism , Capsaicin/pharmacology , Cell Cycle/drug effects , Leptin/metabolism , Lipoprotein Lipase/genetics , Lipoprotein Lipase/metabolism , Mice , PPAR gamma/genetics , PPAR gamma/metabolism , Triglycerides/metabolism
2.
Article in English | WPRIM (Western Pacific) | ID: wpr-316364

ABSTRACT

Epigallocatechin-3-gallate (EGCG) has shown remarkably anti-cancer activity, with its bioactivity being related to reactive conditions, such as pH and metal ions. The present study investigated the degradation of EGCG and its effect on prostate cancer cell in the presence of Cu2+. EGCG was incubated with prostate cancer cells, LNCaP, pretreated with or without Cu2+. EGCG in F-12 medium was quantified using HPLC and the viability of cells was assessed by gel electrophoresis, flow cytometry, and electron microscope. The results of HPLC showed that EGCG degraded completely within 12 h in F-12 medium with or without Cu2+. Gel electrophoresis and flow cytometry did not detect apoptosis of LNCaP cells when they were incubated with EGCG. Electron microscopy examination revealed that EGCG-Cu2+ complex led to damage of cytoplasm membrane in LNCaP cells. It was speculated that not EGCG, but its oxide and complex with Cu2+, are the bioactive components responsible for its cytotoxicity to LNCaP prostate cancer cells.


Subject(s)
Humans , Male , Anticarcinogenic Agents , Apoptosis , Catechin , Cell Line, Tumor , Cell Proliferation , Cell Survival , Copper , Metabolism , Dose-Response Relationship, Drug , Drug Combinations , Prostatic Neoplasms , Drug Therapy , Pathology
SELECTION OF CITATIONS
SEARCH DETAIL